ERNAW Earnings Ernexa Therapeutics Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Quarterly results
EPS
Reported EPS history
1–32 of 32
| Q2 2026 | 2026-06-30 | -9.63 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -6.95 | 2026-05-11 | 10-Q |
| FY 2025 | 2025-12-31 | -2.24 | 2026-03-13 | 10-K |
| Q3 2025 | 2025-09-30 | -2.23 | 2025-11-07 | 10-Q |
| Q2 2026 | 2025-06-30 | -65.22 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -57.76 | 2026-05-11 | 10-Q |
| FY 2025 | 2024-12-31 | -48.96 | 2026-03-13 | 10-K |
| Q3 2025 | 2024-09-30 | -107.45 | 2025-11-07 | 10-Q |
| Q2 2025 | 2024-06-30 | -33.75 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.23 | 2025-05-07 | 10-Q |
| FY 2024 | 2023-12-31 | -4.08 | 2025-03-12 | 10-K |
| Q3 2024 | 2023-09-30 | -2.94 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.90 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.06 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -8.06 | 2024-03-14 | 10-K |
| Q3 2023 | 2022-09-30 | -7.04 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -4.55 | 2023-08-11 | 10-Q |
| Q1 2023 | 2022-03-31 | -3.50 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -56.61 | 2023-03-20 | 10-K |
| Q3 2022 | 2021-09-30 | -56.79 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.81 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.67 | 2022-07-01 | 10-Q |
| FY 2021 | 2020-12-31 | -1.51 | 2022-04-15 | 10-K |
| Q3 2021 | 2020-09-30 | -0.29 | 2021-11-12 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.17 | 2021-08-13 | 10-Q |
| Q1 2021 | 2020-03-31 | -0.06 | 2021-05-17 | 10-Q |
| Q3 2018 | 2018-09-30 | -0.12 | 2018-11-09 | 10-Q |
| Q3 2018 | 2017-09-30 | -0.18 | 2018-11-09 | 10-Q |
| Q3 2013 | 2013-09-30 | -0.01 | 2013-11-14 | 10-Q |
| Q3 2013 | 2012-09-30 | -0.02 | 2013-11-14 | 10-Q |
| Q3 2012 | 2011-09-30 | -0.04 | 2012-11-09 | 10-Q |
| Q3 2011 | 2010-09-30 | -0.01 | 2011-11-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.